China
583 verified figures tagged CN, covering 12 industrys and 396 indicators. The same code is used in every hub — this page gathers them.
Country CN · CHN · ISO-3166
The short version
Key takeaways
Drawn from every industry that publishes a figure for China.
- First-in-class drug approvals in China stood at 11 in 2025 (NHSA). NHSA ↗ T1 Official
- Electronic information manufacturing sector revenue in China totalled 17.4 trillion CNY in 2025 (MIIT). MIIT ↗ T1 Official
- Telecommunications business revenue in China totalled 1.75 trillion CNY in 2025 (MIIT). MIIT ↗ T1 Official
- Semiconductor materials market revenue in China totalled 15.6 billion USD in 2025 (SEMI). SEMI ↗ T2 National
- Innovative drug licensing-out upfront payment value in China stood at 70 billion USD in 2025 (MOFCOM). MOFCOM ↗ T1 Official
- Innovative drug out-licensing deal value in China stood at 1,300 billion USD in 2025 (NHSA). NHSA ↗ T1 Official
- Electric car sales in China totalled 13 million in 2025 (IEA). IEA ↗ T1 Official
- Automobile production in China (all powertrains) totalled 34.5 million in 2025 (CAAM). CAAM ↗ T1 Official
- Integrated circuit production volume in China totalled 484.3 billion in 2025 (MIIT). MIIT ↗ T1 Official
- Mobile broadband Internet traffic in China (annual) totalled 395.8 exabytes in 2025 (MIIT). MIIT ↗ T1 Official
By industry
Industries covering China
Each link opens the industry×country page when one exists, otherwise the industry hub. The count is how many verified rows carry code CN.
| Industry | Data points | Open |
|---|---|---|
| Pharmaceuticals in China C21 | 199 | Country page → |
| Electricity and Gas Utilities in China D35 | 112 | Country page → |
| Construction in China F41 | 57 | Country page → |
| Retail in China G47 | 52 | Country page → |
| Steel and Basic Metals in China C24 | 49 | Country page → |
| Electric Vehicles in China C29 | 38 | Country page → |
| Healthcare in China Q86 | 26 | Country page → |
| Telecommunications in China J61 | 20 | Country page → |
| Semiconductors in China C26 | 12 | Country page → |
| Insurance in China K65 | 7 | Country page → |
| Airlines and Air Transport in China H51 | 6 | Country page → |
| Oil and Gas in China B06 | 5 | Country page → |
By measure
Indicators
- Electricity demand growth 10
- First-in-class drug approvals 9
- Innovative drug approvals 5
- Innovative drug out-licensing deal value 5
- Clinical trial registrations 4
- Electric car exports 4
- Electric car sales 4
- Innovative drug out-licensing deal count 4
- Innovative drug out-licensing deal value (half year) 4
- New energy vehicle production 4
- Rebar market price 4
- Reimbursement drug list total drugs 4
- Semiconductor sales growth (annual) 4
- Angle steel market price 3
- Catering industry income 3
- Catering industry income growth rate year on year 3
380 more indicators appear in the table below.
The complete table
All China data points
Grouped by indicator. Every row links to its full record. The CSV keeps the region code and provenance columns so exports stay citable.
583 data points across 396 indicators. Each line shows the latest value; open a line for earlier periods and forecasts.
5G base stations +1 more 20254.84 millionMIITT12026actual→
5G share of mobile subscriptions +1 more 202565.9%MIITT12026actual→
5G subscriptions +1 more 20251.2 billionMIITT12026actual→
Agricultural insurance premium growth202420%Swiss ReT22024forecast→
Air passengers carried +1 more 2024730 millionCAACT12025estimate→
Alzheimer's disease innovative drug clinical trial approvals (multi-year total)2023–20248NMPAT12024actual→
Angle steel market price +2 more as of 31 Aug 20263,435.4 CNYNBS ChinaT12026actual→
Angle steel market price (CNY per tonne)September 20263,469.8 CNY per tonneNBS ChinaT12026actual→
Antibody-drug conjugate approvals20253DIAT22025actual→
Approved Class 1 innovative drugs202576NHSAT12025actual→
Approved Class 1 innovative drugs (half year)as of 30 Jun 202638NHSAT12026actual→
Approved drug marketing registration applications (half year)as of 30 Jun 20262,318NHSAT12026actual→
Approved innovative drugs designated as breakthrough therapies +1 more 202413State CouncilT12024actual→
Approved innovative drugs growth rate202558.3%MOFCOMT12025actual→
Approved innovative drugs with new targets or mechanisms202511NHSAT12025actual→
Approved innovative drugs with new targets or mechanisms (half year)as of 30 Jun 202611NHSAT12026actual→
Approved novel drugs in breakthrough therapy programs202413NMPAT12024actual→
Automobile production (all powertrains) +1 more 202534.5 millionCAAMT12026actual→
Average daily electricity generationJuly 202630.4 billion kilowatt-hoursNBS ChinaT12026actual→
Average lithium-ion battery pack price +1 more 202494 USD/kWhBNEFT12024actual→
Beneficiaries of negotiated reimbursement drugs +1 more as of 31 Oct 2024830 millionNHSAT12024actual→
- as of 31 Oct 2024830 millionState CouncilT12024actual→
Bioequivalence trials20252,218NHSAT12025actual→
Bioequivalence trials share202542.5%NHSAT12025actual→
Biologic therapy approvals202540DIAT22025actual→
Bispecific antibody approvals20254DIAT22025actual→
Breast cancer drug approvals20259DIAT22025actual→
Carbon intensity of electricity generation +1 more 2024565 gCO2/kWhIEAT12024actual→
Carbon intensity of electricity generation annual decline rate2024–20265%IEAT12026forecast→
Catering industry income +2 more August 2026454.4 billion CNYNBS ChinaT12026actual→
Catering industry income growth rate year on year +2 more August 20261.1%NBS ChinaT12026actual→
Cell therapy approvals20253DIAT22025actual→
Cellular IoT connections +1 more 20252.89 billionMIITT12026actual→
Centralized procurement drugs added to national reimbursement drug listas of 28 Nov 20242NHSAT12024actual→
Change in regional share of global clinical trial country uses2019–202357%IQVIA2023actual→
China wind turbine market share202567%GWECT22025actual→
China's share of PV manufacturing capacity by 2030203080%IEAT12030forecast→
Chinese OEMs' domestic installation share202593.4%GWECT22025actual→
Chinese suppliers among top 15 global wind turbine suppliers20259GWECT22025actual→
Chinese suppliers' share of Chinese wind turbine market2025100%GWECT22025actual→
Chinese wind turbine capacity installed outside China20259,319 MWGWECT22025actual→
Class 1 innovative drug clinical trials20252,171NHSAT12025actual→
Class 1 innovative drug clinical trials growth rate20254.1%NHSAT12025actual→
Class 1 innovative drug clinical trials share202572.4%NHSAT12025actual→
Clinical trial country use share +2 more 202315%IQVIA2023actual→
Clinical trial country use share change2019–202357%IQVIA2023actual→
Clinical trial registrations +3 more 20255,215NHSAT12025actual→
- 20234,300State CouncilT12023actual→
- 20223,410State CouncilT12022actual→
- 20213,358State CouncilT12021actual→
Clinical trial registrations growth rate20256.4%NHSAT12025actual→
Construction business activity expectation index (monthly)August 202651.8%NBS ChinaT12026actual→
Construction business activity index (monthly)August 202646.9%NBS ChinaT12026actual→
Construction employment index (monthly)August 202643%NBS ChinaT12026actual→
Construction input price index (monthly)August 202651.2%NBS ChinaT12026actual→
Construction new order index (monthly)August 202642.4%NBS ChinaT12026actual→
Construction sales price index (monthly)August 202649.8%NBS ChinaT12026actual→
Conventional medicine approvals202580DIAT22025actual→
Country share of clinical trial country-uses2021–202313%IQVIA2023actual→
Country share of global renewable capacity expansion2019–202440%IEAT12024forecast→
Crude steel production +2 more July 202676.9 million tonnesNBS ChinaT12026actual→
- May 202684.4 million tonnesworldsteelT22026actual→
- January 202675.3 million tonnesworldsteelT22026estimate→
Crude steel production (year to date) +1 more as of 31 Jul 2026577 million tonnesNBS ChinaT12026actual→
- as of 31 May 2026415.5 million tonnesworldsteelT22026actual→
Crude steel production growth +2 more July 2026-3.6%NBS ChinaT12026actual→
- May 2026-2.7%worldsteelT22026actual→
- January 2026-13.9%worldsteelT22026estimate→
Crude steel production growth (year to date) +1 more as of 31 Jul 2026-3.1%NBS ChinaT12026actual→
- as of 31 May 2026-3.9%worldsteelT22026actual→
Cumulative drug approval applications under priority reviewend of 2024496State CouncilT12024actual→
Cumulative drug approval applications under priority review (annual)2020–2024496NMPAT12024actual→
Cumulative drugs added via negotiation in reimbursement drug listas of 28 Nov 2024530NHSAT12024actual→
Cumulative drugs removed from reimbursement drug listas of 28 Nov 2024438NHSAT12024actual→
Cumulative health insurance fund payout for negotiated medicinesas of 31 Oct 2024350 billion CNYState CouncilT12024actual→
Cumulative negotiated drug sales during agreement periodas of 31 Oct 2024510 billion CNYState CouncilT12024actual→
Cumulative newly added drugs in reimbursement drug listas of 28 Nov 2024835NHSAT12024actual→
Cumulative patient burden reduction from negotiated drugsas of 31 Oct 2024880 billion CNYNHSAT12024actual→
Deposits and advance receipts for real estate developmentJanuary 20261,437.6 billion CNYNBS ChinaT12026actual→
Domestic air passengers carried2024640 millionCAACT12024estimate→
Domestic airline RPK growth +1 more 202412.3%IATAT22025actual→
Domestic contribution to new entrant increase202581%DIAT22025actual→
Domestic developer drug approvals202563DIAT22025actual→
Domestic developer share of drug approvals202552%DIAT22025actual→
Domestic first-in-class drug approvals +1 more 20254NHSAT12025actual→
Domestic innovative biological product approvals +1 more 202521NHSAT12025actual→
Domestic innovative chemical drug approvals +1 more 202538NHSAT12025actual→
Domestic innovative drug approvals (half year) +1 more as of 30 Jun 202631State CouncilT12026actual→
Domestic loans for real estate developmentJanuary 2026630 billion CNYNBS ChinaT12026actual→
Domestic share of approved innovative biological products +1 more 202591.3%NHSAT12025actual→
Domestic share of approved innovative chemical drugs +1 more 202580.8%NHSAT12025actual→
Domestic-only oncology NAS launches (cumulative)2020–202445IQVIA2024actual→
Domestic-only oncology novel active substance launches (multi-year total)2020–202445IQVIA2024actual→
Drug approval applications completed under priority review +1 more 2024110State CouncilT12024actual→
Drug clinical trials20255,000NHSAT12025actual→
Drugs in commercial health insurance innovative drug catalog +1 more as of 7 Dec 202519SCIOT12025actual→
- as of 7 Dec 202519State CouncilT12025actual→
Drugs removed from national reimbursement drug list +1 more 202529NHSAT12025actual→
- 202443State CouncilT12024actual→
Drugs removed from national reimbursement drug list (year to date)as of 28 Nov 202443NHSAT12024actual→
Electric car exports +3 more 20252.5 millionIEAT12026actual→
Electric car fleet in circulationend of 202544 millionIEAT12026estimate→
Electric car sales +3 more 202513 millionIEAT12026actual→
Electric car sales growth rate +1 more 202440%IEAT12025actual→
Electric cars as a share of new car sales +1 more 202555%IEAT12026actual→
Electric cars as a share of the car fleetend of 202513%IEAT12026estimate→
Electricity and heat power utility business revenue growth rateJanuary 20260.6%NBS ChinaT12026actual→
Electricity and heat power utility operating costs growth rateJanuary 20261.9%NBS ChinaT12026actual→
Electricity and heat power utility total profits growth rateJanuary 2026-8%NBS ChinaT12026actual→
Electricity demand growth +9 more 20247%IEAT12024actual→
Electricity generation (kilowatt-hours) (year to date)as of 31 Jul 20265,698.5 billion kilowatt-hoursNBS ChinaT12026actual→
Electricity generation (monthly)July 2026943.9 billion kilowatt-hoursNBS ChinaT12026actual→
Electricity generation CO2 emissions annual change rate2025–20261%IEAT12026forecast→
Electricity generation growth rateJuly 2026-0.1%NBS ChinaT12026actual→
Electricity generation growth rate (year to date)as of 31 Jul 20263%NBS ChinaT12026actual→
Electricity, heat, gas and water production and supply value added growthAugust 20264.9%NBS ChinaT12026actual→
Electricity, heat, gas and water utility asset-liability ratioas of 31 Jul 202660.6%NBS ChinaT12026actual→
Electricity, heat, gas and water utility business revenue growth rateJanuary 20260.9%NBS ChinaT12026actual→
Electricity, heat, gas and water utility operating costs growth rateJanuary 20261.9%NBS ChinaT12026actual→
Electricity, heat, gas and water utility profit rate of business revenueJanuary 20266.51%NBS ChinaT12026actual→
Electricity, heat, gas and water utility total profitsJanuary 2026478.4 billion CNYNBS ChinaT12026actual→
Electricity, heat, gas and water utility total profits growth rateJanuary 2026-5.8%NBS ChinaT12026actual→
Electronic information manufacturing sector revenue +1 more 202517.4 trillion CNYMIITT12026actual→
Ethanol blending rateas of 1 Jan 201910%IEAT12019actual→
Ferrous metal ores mining and processing producer price index growth (year-on-year) +1 more August 20261.1%NBS ChinaT12026actual→
Ferrous metal smelting and pressing value added growth rateJuly 20260.3%NBS ChinaT12026actual→
Ferrous metal smelting and pressing value added growth rate (year to date)as of 31 Jul 20261.8%NBS ChinaT12026actual→
Ferrous metals purchasing price index growth (year-on-year) +1 more August 20260.3%NBS ChinaT12026actual→
Ferrous metals smelting and pressing producer price index growth (year-on-year) +1 more August 2026-0.3%NBS ChinaT12026actual→
First global drug approvals202561DIAT22025actual→
First-in-class drug approvals +8 more 202511NHSAT12025actual→
Fixed broadband subscriptions +1 more 2025691 millionMIITT12026actual→
Float flat glass market price +1 more August 20261,074.1 CNY per tonneNBS ChinaT12026actual→
Float flat glass market price (snapshot)as of 10 Sep 20261,074.9 CNYNBS ChinaT12026actual→
Float flat glass market price changeas of 10 Sep 20260.8 CNYNBS ChinaT12026actual→
Float flat glass market price change rateas of 10 Sep 20260.1%NBS ChinaT12026actual→
Floor space of buildings completedJanuary 2026191.9 million square metersNBS ChinaT12026actual→
Floor space of buildings completed growth rateJanuary 2026-23.2%NBS ChinaT12026actual→
Floor space of buildings for commercial business for saleas of 31 Jul 202613,535 square metersNBS ChinaT12026actual→
Floor space of buildings newly startedJanuary 2026267 million square metersNBS ChinaT12026actual→
Floor space of buildings newly started growth rateJanuary 2026-24%NBS ChinaT12026actual→
Floor space of buildings under constructionJanuary 20265,575.7 million square metersNBS ChinaT12026actual→
Floor space of commercial buildings for saleas of 31 Jul 2026759.1 million square metersNBS ChinaT12026actual→
Floor space of newly built commercial buildings soldJanuary 2026450.2 million square metersNBS ChinaT12026actual→
Floor space of newly built residential buildings soldJanuary 202637,425 square metersNBS ChinaT12026actual→
Floor space of residential buildings completedJanuary 2026134.4 million square metersNBS ChinaT12026actual→
Floor space of residential buildings newly startedJanuary 2026194.9 million square metersNBS ChinaT12026actual→
Floor space of residential buildings under constructionJanuary 20263,870.5 million square metersNBS ChinaT12026actual→
Funds for real estate developmentJanuary 20264,574.8 billion CNYNBS ChinaT12026actual→
Fusion protein approvals20253DIAT22025actual→
Gas utility business revenue growth rateJanuary 20262.4%NBS ChinaT12026actual→
Gas utility operating costs growth rateJanuary 20262.4%NBS ChinaT12026actual→
Gas utility total profits growth rateJanuary 20269.3%NBS ChinaT12026actual→
Gigabit (1000 Mbps and above) broadband subscribers +1 more 2025238 millionMIITT12026actual→
Health and social services investment growth rateJanuary 2026-13%NBS ChinaT12026actual→
Health care and medical services price index growth rate +2 more August 20262.7%NBS ChinaT12026actual→
Health sector research and development investment growth rate20240.1%European CommissionT12025actual→
Hydropower capacity under constructionas of 24 Jun 2026300 GWIHAT22026actual→
Hydropower generation growth rateJuly 20266.7%NBS ChinaT12026actual→
Hydropower generation growth rate (monthly) +1 more July 20266.7%NBS ChinaT12026actual→
Imported drug approvals202557DIAT22025actual→
Imported drug share of approvals202548%DIAT22025actual→
Imported innovative biological product approvals +1 more 20252NHSAT12025actual→
Imported innovative chemical drug approvals +1 more 20259NHSAT12025actual→
Individual mortgage loans for real estate developmentJanuary 2026604 billion CNYNBS ChinaT12026actual→
Innovative biological product approvals +1 more 202523NHSAT12025actual→
Innovative biological product approvals (half year)as of 30 Jun 202617NHSAT12026actual→
Innovative chemical drug approvals +1 more 202547NHSAT12025actual→
Innovative chemical drug approvals (half year)as of 30 Jun 202620NHSAT12026actual→
Innovative drug approvals +4 more 202576NHSAT12025actual→
Innovative drug approvals (half year) +1 more as of 30 Jun 202638State CouncilT12026actual→
Innovative drug approvals (year to date)as of 15 Apr 202614NHSAT12026actual→
Innovative drug licensing-out upfront payment value202570 billion USDMOFCOMT12025actual→
Innovative drug negotiation success rate202490%State CouncilT12024actual→
Innovative drug out-licensing deal count +3 more 2025150NHSAT12025actual→
Innovative drug out-licensing deal count (half year)as of 30 Jun 202681NHSAT12026actual→
Innovative drug out-licensing deal value +4 more 20251,300 billion USDNHSAT12025actual→
Innovative drug out-licensing deal value (half year) +3 more as of 30 Jun 2026100 billion USDState CouncilT12026actual→
Innovative drugs added to national health insurance catalog +1 more as of 7 Dec 202550SCIOT12025actual→
- as of 7 Dec 202550State CouncilT12025actual→
Innovative drugs added to national health insurance drug listas of 4 Sep 2026199State CouncilT12026actual→
Innovative drugs approved via priority review pathway +1 more 202417State CouncilT12024actual→
Innovative drugs granted conditional market approval +1 more 202411State CouncilT12024actual→
Innovative traditional medicine approvals +1 more 20256NHSAT12025actual→
Innovative traditional medicine approvals (half year)as of 30 Jun 20261NHSAT12026actual→
Integrated circuit production volume +1 more 2025484.3 billionMIITT12026actual→
International air passengers carried202460 millionCAACT12024estimate→
International multi-center clinical trials2025410NHSAT12025actual→
International multi-center clinical trials share202513.7%NHSAT12025actual→
Investment in commercial business buildingsJanuary 20262,809 CNYNBS ChinaT12026actual→
Investment in construction and installation growth rateJanuary 2026-9.2%NBS ChinaT12026actual→
Investment in office buildingsJanuary 20261,580 CNYNBS ChinaT12026actual→
Investment in production and supply of electricity, heat power, gas and water growth rateJanuary 2026-5.3%NBS ChinaT12026actual→
Life insurance premium growth (real) +1 more 202312.5%Swiss ReT22023actual→
Liquefied natural gas import growth rate +1 more Q1 2025-20%IEAT12025actual→
Liquefied natural gas market priceas of 20 Aug 20265,572.8 CNYNBS ChinaT12026actual→
Liquefied natural gas wholesale priceAugust 20265,724.6 CNYNBS ChinaT12026actual→
Lithium iron phosphate market priceas of 31 Aug 202656,905.4 tonNBS ChinaT12026actual→
Lithium iron phosphate priceas of 20 Aug 202656,114.5 CNY/tonneNBS ChinaT12026actual→
Lithium iron phosphate price (CNY/ton)as of 10 Sep 202655,800.8 CNY/tonNBS ChinaT12026actual→
Lithium iron phosphate price changeas of 20 Aug 20262,382 CNY/tonneNBS ChinaT12026actual→
Lithium iron phosphate price change (CNY/ton)as of 10 Sep 2026-1,104.6 CNY/tonNBS ChinaT12026actual→
Lithium iron phosphate price change (ton)as of 31 Aug 2026790.9 tonNBS ChinaT12026actual→
Lithium iron phosphate price change rateas of 10 Sep 2026-1.9%NBS ChinaT12026actual→
Lithium iron phosphate price growth rate +1 more as of 31 Aug 20261.4%NBS ChinaT12026actual→
Manufacture of medicines producer price index growth rate (monthly) +1 more August 2026-0.2%NBS ChinaT12026actual→
Medical services price index (monthly) +1 more August 20260.1%NBS ChinaT12026actual→
Medicine usage index +1 more end of 2030196IQVIA2030forecast→
Medicine use index (2020=100) +1 more 2020100 indexIQVIA2020actual→
Medicines added to national health insurance drug listas of 4 Sep 2026949State CouncilT12026actual→
Mobile broadband Internet traffic (annual)2025395.8 exabytesMIITT12026actual→
Mobile-cellular subscriptions +1 more 20251.83 billionMIITT12026actual→
Mobile-cellular subscriptions per 100 inhabitants +1 more 2025130 per 100 inhabitantsMIITT12026actual→
Monoclonal antibody approvals202518DIAT22025actual→
Monoclonal antibody share of new drug approvals202515%DIAT22025actual→
Mortality insurance protection gap202373.6 billion USDSwiss ReT22023actual→
Mortality insurance protection gap change20236%Swiss ReT22023actual→
Mortality insurance resilience index +1 more 202338.3%Swiss ReT22023actual→
Natural gas average daily productionJuly 2026690 million cubic metersNBS ChinaT12026actual→
Natural gas demand growth rate (quarterly) +1 more Q1 2025-1%IEAT12025estimate→
Natural gas production (cubic meters) (year to date)as of 31 Jul 2026154.3 billion cubic metersNBS ChinaT12026actual→
Natural gas production (monthly)July 202621.4 billion cubic metersNBS ChinaT12026actual→
Natural gas production growth rateas of 31 Jul 20261.2%NBS ChinaT12026actual→
Natural gas production growth rate (monthly)July 2026-0.9%NBS ChinaT12026actual→
Negotiated or bid drugs added to national reimbursement drug listas of 28 Nov 202489NHSAT12024actual→
Negotiated or bid drugs added to national reimbursement drug list (annual)202489State CouncilT12024actual→
Negotiated pharmaceutical sales driven by medical insuranceas of 28 Feb 2026740 billion CNYNHSAT12026actual→
New drug approvals +1 more 2025120DIAT22025actual→
New drug clinical trial initiation time reduction20254 monthsNHSAT12025actual→
New drug clinical trials +1 more 20252,997NHSAT12025actual→
New drug clinical trials growth rate202518%NHSAT12025actual→
New drug clinical trials share +1 more 202557.5%NHSAT12025actual→
New energy vehicle exports +1 more 20252.62 millionCAAMT12026actual→
New energy vehicle production +3 more 202516.5 millionNBS ChinaT12026actual→
New energy vehicle sales +1 more 202516.5 millionCAAMT12026actual→
New energy vehicle stock +1 more end of 202544 millionNBS ChinaT12026actual→
New hydropower capacity added202414.4 GWIHAT22024actual→
New pumped storage hydropower capacity added20247.75 GWIHAT22024actual→
New wind power capacity installed2025120.5 gigawattsGWECT22025actual→
Newly added drugs in national reimbursement drug list +2 more as of 7 Dec 2025114SCIOT12025actual→
- as of 7 Dec 2025114State CouncilT12025actual→
- as of 28 Nov 202491NHSAT12024actual→
Newly added drugs in national reimbursement drug list (annual) +1 more 2025114NHSAT12025actual→
- 202491State CouncilT12024actual→
Novel active substances launched exclusively in China +1 more 202530IQVIA2025actual→
Novel drug approvals via priority review pathway202417NMPAT12024actual→
Novel drugs granted conditional market approval202411NMPAT12024actual→
Nuclear electricity generation growth20206%IEAT12020actual→
Nuclear power generation growth rateJuly 20266.6%NBS ChinaT12026actual→
Off-catalog drugs participating in price negotiation or biddingas of 28 Nov 2024117NHSAT12024actual→
Oil demand displaced by electric vehicles20251 million barrels per dayIEAT12026estimate→
Oncology novel active substance (NAS) launches (cumulative) +1 more 2020–202484IQVIA2024actual→
Oncology novel active substance launches (multi-year total) +1 more 2020–202484IQVIA2024actual→
Online retail sales of goodsJanuary 20267,396.5 billion CNYNBS ChinaT12026actual→
Online retail sales of goods (year to date)as of 31 Aug 20268,419.5 billion CNYNBS ChinaT12026actual→
Online retail sales of goods and servicesJanuary 202611,721.4 billion CNYNBS ChinaT12026actual→
Online retail sales of goods and services (year to date)as of 31 Aug 202613,476.6 billion CNYNBS ChinaT12026actual→
Online retail sales of goods and services growth rate year on yearJanuary 20264.8%NBS ChinaT12026actual→
Online retail sales of goods growth rate year on yearJanuary 20264.6%NBS ChinaT12026actual→
Online retail sales of goods growth rate year on year (year to date)as of 31 Aug 20264.3%NBS ChinaT12026actual→
Online retail sales of servicesJanuary 20264,324.9 billion CNYNBS ChinaT12026actual→
Online retail sales of services (year to date)as of 31 Aug 20265,057.1 billion CNYNBS ChinaT12026actual→
Online retail sales of services growth rate year on yearJanuary 20265.2%NBS ChinaT12026actual→
Online retail sales value growth (year to date)as of 31 Aug 20264.6%NBS ChinaT12026actual→
Ordinary hot-rolled sheet market priceAugust 20263,326.4 CNY per tonneNBS ChinaT12026actual→
Ordinary medium plate market priceAugust 20263,526.9 CNY per tonneNBS ChinaT12026actual→
Ordinary Portland cement market price +1 more August 2026248.7 CNY per tonneNBS ChinaT12026actual→
Ordinary Portland cement market price (snapshot)as of 10 Sep 2026250.7 CNYNBS ChinaT12026actual→
Ordinary Portland cement market price changeas of 10 Sep 20262 CNYNBS ChinaT12026actual→
Ordinary Portland cement market price change rate +1 more August 2026-0.2%NBS ChinaT12026actual→
Ordinary Portland cement market price change rate (snapshot)as of 10 Sep 20260.8%NBS ChinaT12026actual→
Pediatric medicine approvals +2 more 2024106NMPAT12024actual→
- 2024106State CouncilT12024actual→
- 2024106NMPAT12024actual→
Peptide therapy approvals20254DIAT22025actual→
Pharmaceutical export delivery value growth (half year) +1 more as of 30 Jun 20269%State CouncilT12026actual→
Pharmaceutical industry export delivery value (half year) +2 more as of 30 Jun 2026210 billion CNYState CouncilT12026actual→
- as of 30 Jun 202630.9 billion USDState CouncilT12026actual→
- as of 30 Jun 2026210 billion CNYMOFCOMT12026actual→
Pharmaceutical industry R&D expenditure growth rate2021–202523%NHSAT12025actual→
Pharmaceutical industry total profit growth rate2021–202511.3%NHSAT12025actual→
Pharmaceutical manufacturing investment growth rateJanuary 2026-9.8%NBS ChinaT12026actual→
Pharmaceutical value-added industrial output growth (half year) +1 more as of 30 Jun 20266.4%State CouncilT12026actual→
Pig iron productionJuly 202668.3 million tonnesNBS ChinaT12026actual→
Pig iron production (year to date)as of 31 Jul 2026495.8 million tonnesNBS ChinaT12026actual→
Pig iron production growth rateJuly 2026-4.5%NBS ChinaT12026actual→
Pig iron production growth rate (year to date)as of 31 Jul 2026-3%NBS ChinaT12026actual→
Planned capacity additions2026–202838.6 million tonnesOECDT12028forecast→
Polysilicon market priceas of 31 Aug 202640.5 kgNBS ChinaT12026actual→
Polysilicon priceas of 20 Aug 202635.4 CNY/kilogramNBS ChinaT12026actual→
Polysilicon price (CNY/kg)as of 10 Sep 202640.9 CNY/kgNBS ChinaT12026actual→
Polysilicon price changeas of 20 Aug 20263.9 CNY/kilogramNBS ChinaT12026actual→
Polysilicon price change (CNY/kg)as of 10 Sep 20260.4 CNY/kgNBS ChinaT12026actual→
Polysilicon price change (kg)as of 31 Aug 20265.1 kgNBS ChinaT12026actual→
Polysilicon price change rateas of 10 Sep 20261%NBS ChinaT12026actual→
Polysilicon price growth rate +1 more as of 31 Aug 202614.4%NBS ChinaT12026actual→
Priority review drug approval applications completed growth rate +1 more 202429%State CouncilT12024actual→
Producer price index for electricity and heat power production and supply year-on-year growth rateAugust 2026-3.6%NBS ChinaT12026actual→
Producer price index for gas production and supply year-on-year growth rateAugust 20264.2%NBS ChinaT12026actual→
Projected patient out-of-pocket burden reduction202550 billion CNYState CouncilT12025forecast→
Public charging points added2024850 thousandIEAT12025estimate→
Public fast charging pointsend of 20241.6 millionIEAT12025estimate→
Pumped storage capacity commissioned20257,500 MWIHAT22025actual→
Pumped storage capacity under constructionas of 24 Jun 2026218 GWIHAT22026actual→
Radiopharmaceutical market size203026 billion CNYNHSAT12030forecast→
Rare disease drug varieties approved202439State CouncilT12024actual→
Rare disease medicine approvals +2 more 202455NMPAT12024actual→
- 202455State CouncilT12024actual→
- 202455NMPAT12024actual→
Real estate development investmentJanuary 20264,300.9 billion CNYNBS ChinaT12026actual→
Rebar market price +3 more as of 31 Aug 20263,130.3 CNYNBS ChinaT12026actual→
Rebar market price (CNY per tonne)September 20263,182.7 CNY per tonneNBS ChinaT12026actual→
Rebar market price (snapshot)as of 10 Sep 20263,182.7 CNYNBS ChinaT12026actual→
Rebar market price change rate +1 more August 20262.2%NBS ChinaT12026actual→
Rebar market price change rate (snapshot)as of 10 Sep 20261.7%NBS ChinaT12026actual→
Regional share of global clinical trial country uses +1 more end of 202315%IQVIA2023actual→
Reimbursement drug list conventional medicinesas of 28 Nov 20241,765NHSAT12024actual→
Reimbursement drug list conventional medicines (annual)20251,857NHSAT12025actual→
Reimbursement drug list total drugs +3 more as of 7 Dec 20253,253SCIOT12025actual→
- as of 7 Dec 20253,253State CouncilT12025actual→
- as of 28 Nov 20243,159NHSAT12024actual→
- as of 28 Nov 20243,159State CouncilT12024actual→
Reimbursement drug list total drugs (annual)20253,253NHSAT12025actual→
Reimbursement drug list traditional patent medicinesas of 28 Nov 20241,394NHSAT12024actual→
Reimbursement drug list traditional patent medicines (annual)20251,396NHSAT12025actual→
Residential real estate development investmentJanuary 20263,317.2 billion CNYNBS ChinaT12026actual→
Retail sales of building and decoration materials +1 more July 20269.4 billion CNYNBS ChinaT12026actual→
Retail sales of consumer goods excluding automobiles +1 more July 20263,589.2 billion CNYNBS ChinaT12026actual→
Retail sales of consumer goods excluding automobiles growth rate year on year +1 more July 20262.5%NBS ChinaT12026actual→
Retail sales of enterprises above designated size +1 more July 202614,308 CNYNBS ChinaT12026actual→
Retail sales of enterprises above designated size growth rate year on year +1 more July 2026-3.4%NBS ChinaT12026actual→
Retail sales of goods +2 more August 20263,528 billion CNYNBS ChinaT12026actual→
Retail sales of goods growth rate year on year +2 more August 20260.3%NBS ChinaT12026actual→
Retail sales of goods growth rate year on year (year to date)as of 31 Aug 20261%NBS ChinaT12026actual→
Retail sales of services growth rate year on year (year to date)as of 31 Aug 20264.9%NBS ChinaT12026actual→
Rolled steel productionJuly 2026116.5 million tonnesNBS ChinaT12026actual→
Rolled steel production (year to date)as of 31 Jul 2026836.2 million tonnesNBS ChinaT12026actual→
Rolled steel production growth rateJuly 2026-4.1%NBS ChinaT12026actual→
Rolled steel production growth rate (year to date)as of 31 Jul 2026-1.2%NBS ChinaT12026actual→
Rural fixed broadband subscribers +1 more 2025204 millionMIITT12026actual→
Rural retail sales of consumer goods +1 more July 2026524.2 billion CNYNBS ChinaT12026actual→
Rural retail sales of consumer goods growth rate year on year +1 more July 20261.6%NBS ChinaT12026actual→
Sales growth at constant exchange ratesQ1 2026-9%RocheT22026actual→
Sales growth in Swiss francsQ1 2026-12%RocheT22026actual→
Sales value of newly built commercial buildingsJanuary 20264,271.8 billion CNYNBS ChinaT12026actual→
Sales value of newly built commercial buildings growth rateJanuary 2026-13.1%NBS ChinaT12026actual→
Sales value of newly built residential buildingsJanuary 202637,543 CNYNBS ChinaT12026actual→
Seamless steel pipe market price +2 more as of 31 Aug 20264,011.9 CNYNBS ChinaT12026actual→
Seamless steel pipe market price (CNY per tonne)September 20264,026.9 CNY per tonneNBS ChinaT12026actual→
Self-raised funds for real estate developmentJanuary 20261,654.4 billion CNYNBS ChinaT12026actual→
Semi-finished steel export growth2024–2025300%OECDT12025actual→
Semiconductor equipment billings +1 more 202549.3 billion USDSEMIT22026actual→
Semiconductor materials market revenue +1 more 202515.6 billion USDSEMIT22026actual→
Semiconductor sales growth (annual) +3 more 202517.9%WSTST22026actual→
Share of electricity consumption202028%IEAT12020actual→
Share of electricity demand growth202550%IEAT12025forecast→
Share of global battery manufacturing capacityend of 202580%IEAT12026estimate→
Share of global biopharmaceutical licensing deals202520%State CouncilT12025actual→
Share of global biopharmaceutical pipeline +1 more 202530%State CouncilT12025actual→
- 20152%State CouncilT12015actual→
Share of global biopharmaceutical pipeline (snapshot)as of 30 Jun 202630%NHSAT12026actual→
Share of global electric car production +1 more 202575%IEAT12026estimate→
Share of global electric car sales +2 more 202563%BNEFT12026estimate→
Share of global EV battery deployment202560%IEAT12026estimate→
Share of global hydropower capacity additions +1 more 202540%IHAT22025actual→
Share of global new renewable capacity added202360%IEAT12023actual→
Share of global new wind and solar PV capacity installed in China2017–204033.3%IEAT12040forecast→
Share of global oil demand growth2015–202460%IEAT12024actual→
Share of global renewable capacity expansion to 20302024–203060%IEAT12030forecast→
Share of global renewable capacity growth2017–202240%IEAT12022forecast→
Share of global solar cell manufacturing capacityend of 201760%IEAT12017actual→
Share of global solar PV capacity expansion201650%IEAT12016actual→
Share of global solar PV demandend of 201750%IEAT12017actual→
Share of high-value-added products in pharmaceutical exports (half year)as of 30 Jun 202620%MOFCOMT12026actual→
Share of priority review drug approval applications treating cancerend of 202442.5%State CouncilT12024actual→
Share of priority review drug approval applications treating cancer (annual)2020–202442.5%NMPAT12024actual→
Share of renewable capacity additions increase by country202230%IEAT12022forecast→
Share of renewable capacity installations2024–203060%IEAT12030forecast→
Share of renewable power capacityend of 203050%IEAT12030forecast→
Share of renewable power capacity (annual)201033.3%IEAT12010actual→
Small molecule drug approvals202572DIAT22025actual→
Small molecule share of new drug approvals202560%DIAT22025actual→
Solar cell (photovoltaic cell) production growth rate (monthly) +1 more July 2026-9.4%NBS ChinaT12026actual→
Solar power generation growth rateJuly 20265.6%NBS ChinaT12026actual→
Solar power generation growth rate (monthly) +1 more July 20265.6%NBS ChinaT12026actual→
Solar PV and wind capacity target for 203020241,200 billion wattsIEAT12024actual→
Solar PV share of electricity generation2025–202710%IEAT12027forecast→
Steel demand growth +2 more 2025-7.1%worldsteelT22025actual→
- 2026-1.5%worldsteelT22026forecast→
- 2025-2%worldsteelT22025forecast→
Steel export growth2020–2025153%OECDT12025actual→
Steel export share of crude steel production202514%OECDT12025actual→
Steel exports +1 more 2025131 million tonnesAISIT22025actual→
Steel industry business revenue growthJanuary 2026-0.8%NBS ChinaT12026actual→
Steel industry operating costs growthJanuary 2026-0.4%NBS ChinaT12026actual→
Steel industry total profits growthJanuary 2026-51.2%NBS ChinaT12026actual→
Steel wire market price +1 more as of 31 Aug 20263,317.8 CNYNBS ChinaT12026actual→
Successful price negotiations or bids for off-catalog drugsas of 28 Nov 202489NHSAT12024actual→
Telecommunications business revenue20251.75 trillion CNYMIITT12026actual→
Thermal power generation growth rate +1 more July 2026-3.5%NBS ChinaT12026actual→
Top 50 global pharmaceutical companies countas of 15 Apr 20266NHSAT12026actual→
Total retail sales of consumer goods +2 more August 20263,982.4 billion CNYNBS ChinaT12026actual→
Total retail sales of consumer goods (year to date)as of 31 Aug 202632,756.9 billion CNYNBS ChinaT12026actual→
Total retail sales of consumer goods growth rate year on year +2 more August 20260.4%NBS ChinaT12026actual→
Total retail sales of consumer goods growth rate year on year (year to date)as of 31 Aug 20261.1%NBS ChinaT12026actual→
Total retail sales, month-on-month growthAugust 2026-0.13%NBS ChinaT12026actual→
Traditional Chinese medicines price index (monthly) +1 more August 20260%NBS ChinaT12026actual→
Type 2 diabetes drug launches20256DIAT22025actual→
Urban retail sales of consumer goods +2 more August 20263,445.7 billion CNYNBS ChinaT12026actual→
Urban retail sales of consumer goods growth rate year on year +2 more August 20260.2%NBS ChinaT12026actual→
Value added growth rate of pharmaceutical manufacturing +1 more July 20262.8%NBS ChinaT12026actual→
Western medicines price index (monthly) +1 more August 2026-0.1%NBS ChinaT12026actual→
Wind and solar PV capacity additions growth rate202030%IEAT12020forecast→
Wind power generation (monthly)July 202682 billion kWhNBS ChinaT12026actual→
Wind power generation growth rate +1 more July 20264.5%NBS ChinaT12026actual→
Wind power generation growth rate (monthly) +1 more July 20264.5%NBS ChinaT12026actual→
Wind turbine capacity commissioned2025120 GWGWECT22025actual→
Wind turbine capacity installed2025130 GWGWECT22025actual→
Wind turbines installed202518,291GWECT22025actual→
Wire market price +1 more August 20263,317.8 CNY per tonneNBS ChinaT12026actual→
Primary documents
Sources
| Document | Publisher | Authority tier | Published | Accessed | Locator | Data points |
|---|---|---|---|---|---|---|
| BloombergNEF's Electric Vehicle Outlook 2026: Global EV Sales Set For Another Record-Breaking Year, But Growth in Some Major Markets Slows Press release | BNEF | T1 Official | 16 Jun 2026 | 14 Sep 2026 | Key takeaways | 1 |
| Lithium-Ion Battery Pack Prices See Largest Drop Since 2017, Falling to $115 per Kilowatt-Hour Press release | BNEF | T1 Official | 10 Dec 2024 | 14 Sep 2026 | Body text | 2 |
| 2025年我国新能源汽车产销量双超1600万辆 News release | CAAM | T1 Official | 14 Jan 2026 | 14 Sep 2026 | Body text | 8 |
| China's 2024 air passenger traffic hits record high News article | CAAC | T1 Official | 3 Jan 2025 | 14 Sep 2026 | Paragraph 1 | 2 |
| China's air-passenger transport hits record high in 2024 News article | CAAC | T1 Official | 17 Dec 2024 | 14 Sep 2026 | Paragraph 3; Paragraph 4 | 2 |
| The 2025 EU Industrial R&D Investment Scoreboard Press release | European Commission | T1 Official | 22 Dec 2025 | 17 Sep 2026 | EU: Health and energy sectors shine in a year of slowdown | 1 |
| Global EV Outlook 2026 Report | IEA | T1 Official | 20 May 2026 | 14 Sep 2026 | Executive summary | 4 |
| Global EV Outlook 2026 Report | IEA | T1 Official | 20 May 2026 | 14 Sep 2026 | Trends in electric cars | 6 |
| Global EV Outlook 2026 Report | IEA | T1 Official | 20 May 2026 | 14 Sep 2026 | Electric vehicle batteries | 2 |
| Global EV Outlook 2025 Report | IEA | T1 Official | 14 May 2025 | 14 Sep 2026 | Executive summary | 3 |
| Global EV Outlook 2025 Report | IEA | T1 Official | 14 May 2025 | 14 Sep 2026 | Trends in electric car markets | 6 |
| Global EV Outlook 2025 Report | IEA | T1 Official | 14 May 2025 | 14 Sep 2026 | Electric vehicle charging | 2 |
| Emissions: Power generation CO2 emissions are plateauing – Electricity Mid-Year Update 2025 Press release | IEA | T1 Official | — | 15 Sep 2026 | Emissions: Power generation CO2 emissions are plateauing | 4 |
| Executive summary – Renewables 2024 Press release | IEA | T1 Official | — | 16 Sep 2026 | Solar PV and wind manufacturing race continues, but dynamics are changing; 2030 forecast has two main drivers: solar PV and China | 3 |
| Renewables 2019 Press release | IEA | T1 Official | — | 16 Sep 2026 | Solar PV drives strong rebound in renewable capacity additions; China to lead biofuel production growth for the first time | 2 |
| Executive summary – Electricity Mid-Year Update 2025 Press release | IEA | T1 Official | — | 15 Sep 2026 | Global electricity demand on course to expand robustly in 2025 and 2026 despite economic headwinds | 4 |
| Global electricity demand to keep growing robustly through 2026 despite economic headwinds Press release | IEA | T1 Official | — | 15 Sep 2026 | Renewables, natural gas and nuclear are set to meet the additional demand as the world’s use of electricity rises for industry, appliances, air conditioning, data centres, EVs and more | 2 |
| Global electricity demand growth set to accelerate as power systems adjust to recent shocks Press release | IEA | T1 Official | — | 15 Sep 2026 | Industry, electric vehicles, air conditioning and data centres continue to spur robust increases in electricity use around the world | 1 |
| Growth in global electricity demand is set to accelerate in the coming years as power-hungry sectors expand Press release | IEA | T1 Official | — | 15 Sep 2026 | Growth in global electricity demand is set to accelerate in the coming years as power-hungry sectors expand - News - IEA | 3 |
| Electricity Market Report Press release | IEA | T1 Official | — | 15 Sep 2026 | About this report | 4 |
| Executive summary – Gas Market Report, Q3-2025 Press release | IEA | T1 Official | — | 15 Sep 2026 | Natural gas demand in Asia markedly slowed in the first half of 2025 amid macroeconomic uncertainty and tight supply | 2 |
| Global natural gas demand growth set to accelerate in 2026 as more LNG supply comes to market Press release | IEA | T1 Official | — | 15 Sep 2026 | Global natural gas demand growth set to accelerate in 2026 as more LNG supply comes to market | 2 |
| Executive Summary – World Energy Outlook 2024 Press release | IEA | T1 Official | — | 16 Sep 2026 | How fast will clean energy transitions unfold? | 1 |
| World Energy Outlook 2017 Press release | IEA | T1 Official | — | 16 Sep 2026 | When China changes, everything changes | 1 |
| Amid rising geopolitical strains, oil markets face new uncertainties as the drivers of supply and demand growth shift Press release | IEA | T1 Official | — | 15 Sep 2026 | Amid rising geopolitical strains, oil markets face new uncertainties as the drivers of supply and demand growth shift | 1 |
| Market Report Series: Renewables 2017 Press release | IEA | T1 Official | — | 16 Sep 2026 | China is the undisputed renewable growth leader; Renewables accounted for almost two-thirds of net new power capacity | 4 |
| Renewables 2020 Press release | IEA | T1 Official | — | 16 Sep 2026 | Increasing policy certainty in key markets could significantly boost renewables deployment; Renewable power additions defy Covid to set new record | 2 |
| Massive global growth of renewables to 2030 is set to match entire power capacity of major economies today, moving world closer to tripling goal Press release | IEA | T1 Official | — | 16 Sep 2026 | China renewable capacity paragraph | 3 |
| 2025年我国批准创新药76个 对外授权超千亿美元 Press release | MOFCOM | T1 Official | — | 17 Sep 2026 | 2025年我国批准创新药76个 对外授权超千亿美元 | 20 |
| 上半年我国创新药对外技术授权交易额创新高 Press release | MOFCOM | T1 Official | — | 17 Sep 2026 | 上半年我国创新药对外技术授权交易额创新高 | 7 |
| 2025年通信业统计公报 (2025 Communications Industry Statistical Bulletin) Report | MIIT | T1 Official | 28 Jan 2026 | 14 Sep 2026 | 四、网络基础设施情况 - (二)5G网络建设覆盖持续深化; 二、用户发展情况 - (一)移动电话用户规模稳步扩大; 二、用户发展情况 - (三)移动物联网终端用户维持较快增长态势 | 20 |
| China's electronic information manufacturing sector posts rapid growth in 2025 Statistical release | MIIT | T1 Official | 30 Jan 2026 | 14 Sep 2026 | Paragraph 2; Final paragraph | 4 |
| 中华人民共和国2025年国民经济和社会发展统计公报 Statistical release | NBS China | T1 Official | 28 Feb 2026 | 14 Sep 2026 | 一、综合 — 绿色低碳转型成效突出 | 4 |
| Market Prices of Important Means of Production in Circulation, August 21-31, 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Market Prices of Important Means of Production in Circulation (August 21-31, 2026) | 21 |
| Market Prices of Important Means of Production in Circulation, August 11-20, 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Market Prices of Important Means of Production in Circulation (August 11-20, 2026); Market Prices of Important Means of Production in Circulation (August 11-20, 2026) — III. Chemical Products; Market Prices of Important Means of Production in Circulation (August 11-20, 2026) — VI. Non-metallic Mineral Products | 17 |
| Market Prices of Important Means of Production in Circulation, September 1-10, 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Market Prices of Important Means of Production in Circulation (September 1-10, 2026) - I. Ferrous Metals; Market Prices of Important Means of Production in Circulation (September 1-10, 2026); Market Prices of Important Means of Production in Circulation (September 1-10, 2026) — III. Chemical Products | 17 |
| Energy Production in July 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | II. Electricity Generation; I. Raw Coal, Crude Oil and Natural Gas Production and Related Information | 17 |
| National Economy Remained Steady with Innovation-Led and High-Quality Development in August Press release | NBS China | T1 Official | — | 15 Sep 2026 | 3. Market Sales Scaled Up and Service Retails Saw Fast Growth.; 1. Industrial Production Accelerated and Equipment Manufacturing and High-Tech Manufacturing Grew Fast.; 7. Consumer Price Rose Mildly and Producer Prices for Industrial Products Grew Faster Year on Year. | 20 |
| Total Retail Sales of Consumer Goods from January to July 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Total Retail Sales of Consumer Goods from January to July 2026; Total Retail Sales of Consumer Goods in July 2026 | 36 |
| Purchasing Managers’ Index for August 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | II. Non-manufacturing Purchasing Managers’ Index | 6 |
| Industrial Production Operation in July 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Industrial Production Operation in July 2026; Output of Major Industrial Products of Enterprises Above the Designated Size; Value Added of the Main Industries | 25 |
| Investment in Real Estate Development from January to July 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | III. Funds for Investment This Year for Real Estate Development Enterprises; I. The Completion of Investment in Real Estate Development; Table 1 Real Estate Development and Sales from January to July 2026 | 24 |
| Profits of Industrial Enterprises above the Designated Size from January to July in 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Table 3 Key Financial Indicators of Industrial Enterprises above the Designated Size from January to July in 2026 (By Industry); Profits of Industrial Enterprises above the Designated Size from January to July in 2026; Table 2 Performance Indicators of Industrial Enterprises above the Designated Size from January to July in 2026 | 15 |
| Industrial Producer Price Indexes in August 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Industrial Producer Price Indexes in August 2026; Table: Industrial Producer Price Indexes in August 2026 — III. Producer Price Indexes for Major Industries (Growth Rate M/M column); Table: Industrial Producer Price Indexes in August 2026 — III. Producer Price Indexes for Major Industries (Jan-Aug Growth Rate Y/Y column) | 10 |
| Investment in Fixed Assets from January to July 2026 Press release | NBS China | T1 Official | — | 15 Sep 2026 | Table: Investment in Fixed Assets (Excluding Rural Households) from January to July 2026; Investment in Fixed Assets (Excluding Rural Households) from January to July 2026; Investment in Fixed Assets from January to July 2026 | 4 |
| Consumer Price Index in August 2026 Press release | NBS China | T1 Official | — | 16 Sep 2026 | I. Year-on-Year Changes in Price Indexes for Various Goods and Services; Consumer Price Indexes in August 2026 | 8 |
| 国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录 Press release | NHSA | T1 Official | 28 Nov 2024 | 17 Sep 2026 | 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录 | 14 |
| 国家医疗保障局 医保动态 国新办举行国务院政策例行吹风会介绍健全全周期全渠道药品价格形成机制有关情况 Press release | NHSA | T1 Official | — | 17 Sep 2026 | 大众新闻大众日报记者提问; 红星新闻记者提问; 经济日报记者提问 | 7 |
| 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元 Press release | NHSA | T1 Official | — | 17 Sep 2026 | 今年38个1类创新药已获批上市 11款新靶点、新机制药均为国产; 我国上半年创新药对外授权约1100亿美元 创历史新高; 11款新靶点新机制创新药涵盖哪些治疗领域 | 14 |
| 国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升 Press release | NHSA | T1 Official | — | 17 Sep 2026 | 试验包括新药临床试验和生物等效性试验; 新药临床试验近六成 其中超七成是创新药; 从“0”到“1”创新能力增强 我国新药研发热度持续攀升 | 14 |
| 国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2025年版国家基本医疗保险、生育保险和工伤保险药品目录和商业健康保险创新药品目录 Press release | NHSA | T1 Official | — | 17 Sep 2026 | 国家医保局 人力资源社会保障部印发2025年版国家基本医疗保险、生育保险和工伤保险药品目录和商业健康保险创新药品目录 | 7 |
| 国家医疗保障局 医保动态 创新高!去年我国批准创新药76个 对外授权破千亿美元 Press release | NHSA | T1 Official | — | 17 Sep 2026 | 创新高!去年我国批准创新药76个 对外授权破千亿美元 | 17 |
| Measures facilitate approval of 48 first-in-class innovative drugs Press release | NMPA | T1 Official | — | 17 Sep 2026 | Measures facilitate approval of 48 first-in-class innovative drugs | 13 |
| China approves 48 innovative drugs in 2024 Press release | NMPA | T1 Official | — | 17 Sep 2026 | China approves 48 innovative drugs in 2024 | 6 |
| OECD Steel Outlook 2026 Press release | OECD | T1 Official | — | 15 Sep 2026 | Countries with excess capacity are flooding world markets with steel; Trade diversion and suspicious patterns of trade, including circumvention, are undermining the effectiveness of trade actions | 5 |
| China updates national medical insurance catalog, adds 114 new drugs Press release | SCIO | T1 Official | — | 17 Sep 2026 | China updates national medical insurance catalog, adds 114 new drugs | 4 |
| Measures facilitate approval of 48 first-in-class innovative drugs Press release | State Council | T1 Official | — | 17 Sep 2026 | Measures facilitate approval of 48 first-in-class innovative drugs | 12 |
| 2024年版国家医保药品目录出炉,新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网 Press release | State Council | T1 Official | — | 17 Sep 2026 | 7年累计将835种药品新增进入目录; 2024年版国家医保药品目录出炉,新增91种药品——让参保人用上更多新药好药; “全球新”的创新药有38种,创历年新高 | 10 |
| China scales up support for clinical trials, accelerating drug development Press release | State Council | T1 Official | — | 17 Sep 2026 | China scales up support for clinical trials, accelerating drug development | 3 |
| Value of China's innovative drug out-licensing deals hit new high in H1 Press release | State Council | T1 Official | — | 17 Sep 2026 | Value of China's innovative drug out-licensing deals hit new high in H1 | 7 |
| China updates national medical insurance catalog, adds 114 new drugs Press release | State Council | T1 Official | — | 17 Sep 2026 | China updates national medical insurance catalog, adds 114 new drugs | 4 |
| 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网 Press release | State Council | T1 Official | — | 17 Sep 2026 | 大力支持产业创新; 更好满足临床急需 | 2 |
| China to expand health insurance coverage for innovative drugs Press release | State Council | T1 Official | — | 17 Sep 2026 | China to expand health insurance coverage for innovative drugs | 6 |
| AISI Says China Report on 'So Called Excess Capacity' Fundamentally Flawed Press release | AISI | T2 National | — | 15 Sep 2026 | AISI Says China Report on ‘So Called Excess Capacity’ Fundamentally Flawed | 1 |
| 2025 NMPA Approvals: China Clears Record Number of New Drugs Press release | DIA | T2 National | — | 17 Sep 2026 | Established Modalities Maintain a Larger Presence; 2025 NMPA Approvals: China Clears Record Number of New Drugs; The Cancer Sector Continues to Attract the Most Players | 20 |
| GWEC records sharp rise in wind turbine installations, as five OEMs exceed 100 GW Press release | GWEC | T2 National | — | 16 Sep 2026 | China market | 8 |
| Global Wind Day 2026: Fast Facts about Wind Press release | GWEC | T2 National | — | 16 Sep 2026 | 2. We've Seen Record Growth in Recent Years | 1 |
| Global Air Passenger Demand Reaches Record High in 2024 Press release | IATA | T2 National | 30 Jan 2025 | 14 Sep 2026 | Domestic Passenger Markets | 2 |
| World Hydropower Outlook launches The year of the ‘water battery’ Press release | IHA | T2 National | — | 16 Sep 2026 | China strengthens its role as the global leader | 3 |
| World Hydropower Outlook 2025: Global Growth, Trends & Net Zero Progress 2025 World Hydropower Outlook Press release | IHA | T2 National | — | 16 Sep 2026 | China Powers Expansion | 2 |
| The International Hydropower Association (IHA) CEO Eddie Rich has written the following letter on behalf of IHA European members to President Ursula von der Leyen, President of the European Commission Press release | IHA | T2 National | — | 16 Sep 2026 | IHA letter to the European Commission on pumped storage | 1 |
| World Hydropower Outlook 2026: Global Capacity & Data 2026 World Hydropower Outlook Press release | IHA | T2 National | — | 16 Sep 2026 | China drives global development | 1 |
| [Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant a... Press release | Roche | T2 National | 23 Jul 2026 | 15 Sep 2026 | Group results | 2 |
| Global Semiconductor Materials Market Revenue Reaches Record $73.2 Billion in 2025, SEMI Reports Press release | SEMI | T2 National | 12 May 2026 | 14 Sep 2026 | Paragraph on regional materials consumption | 2 |
| SEMI Reports Global Semiconductor Equipment Billings Reached $135 Billion in 2025, Up 15% Year-on-Year Press release | SEMI | T2 National | 7 Apr 2026 | 14 Sep 2026 | Regional paragraph | 2 |
| Global Semiconductor Sales Decrease 8.2% in 2023; Market Rebounds Late in Year Press release | SIA | T2 National | 5 Feb 2024 | 14 Sep 2026 | Paragraph beginning 'On a regional basis...' | 2 |
| sigma Resilience Index 2024: Encouraging resilience gains, but more is needed Press release | Swiss Re | T2 National | — | 15 Sep 2026 | Insurance resilience; Mortality resilience in China: life insurance is a key driver | 5 |
| sigma 3/2024: World insurance: strengthening global resilience with a new lease of life Press release | Swiss Re | T2 National | — | 15 Sep 2026 | Life insurance sector growth 2023, by market | 2 |
| Global Semiconductor Market grows 26% in 2025 to $796 billion (Q4 2025 release) Press release | WSTS | T2 National | 6 Mar 2026 | 14 Sep 2026 | Section 'Regional Markets: Strong Growth in Asia Pacific and the Americas' | 2 |
| May 2026 crude steel production Press release | worldsteel | T2 National | — | 15 Sep 2026 | Top 10 steel-producing countries; Table 2. Top 10 steel-producing countries | 4 |
| January 2026 crude steel production Press release | worldsteel | T2 National | — | 15 Sep 2026 | Top 10 steel-producing countries; Table 2. Top 10 steel-producing countries | 2 |
| worldsteel Short Range Outlook April 2026 Press release | worldsteel | T2 National | — | 15 Sep 2026 | worldsteel Short Range Outlook April 2026 | 3 |
| Rethinking Clinical Trial Country Prioritization Press release | IQVIA | T3 Research | — | 15 Sep 2026 | Key findings; Key findings:; Country utilization is heavily consolidated in U.S., China and Western European countries | 8 |
| Global Oncology Trends 2025 Press release | IQVIA | T3 Research | — | 16 Sep 2026 | Other Findings | 6 |
| Global Medicine Use Trends 2026 Press release | IQVIA | T3 Research | — | 15 Sep 2026 | Report Summary:; Key Findings | 4 |
| Global R&D Trends 2026 Press release | IQVIA | T3 Research | — | 15 Sep 2026 | Key Findings | 1 |
| Global R&D Trends 2026 Press release | IQVIA | T3 Research | — | 15 Sep 2026 | Key Findings | 1 |
Report snapshots are retained internally for verification only and are never redistributed. Where a figure comes from a paywalled report, only the number published in its public summary is recorded.
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0.
Region code CN is stable across the API and every hub.
StatOrigin. (2026). China industry statistics. Retrieved from https://statorigin.org/regions/china